Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

AstraZeneca’s Fasenra set to revolutionize COPD treatment as Phase III data builds anticipation, says GlobalData

AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 J.P. Morgan Healthcare Conference, is set to transform the chronic obstructive pulmonary disease (COPD) treatment. As the first IL-5-targeting monoclonal antibody in late-stage trials, Fasenra targets eosinophilic inflammation, potentially reshaping treatment standards and reinforcing AstraZeneca’s leadership in respiratory and […]
Read more

Simpson Thacher & Bartlett and TriLegal top M&A legal advisers in Asia-Pacific region in 2024, reveals GlobalData

Simpson Thacher & Bartlett and TriLegal were the top mergers and acquisitions (M&A) legal advisers in the Asia-Pacific region in 2024 by value and volume, respectively according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database reveals that Simpson Thacher & Bartlett achieved […]
Read more

South Korea aesthetic injectables market poised for 12% CAGR through 2033, forecasts GlobalData

With an increasing emphasis on achieving natural and youthful aesthetics, the demand for innovative solutions in skin rejuvenation is rapidly growing. Hybrid hyaluronic acid fillers are emerging as game-changers, offering more than hydration and volume restoration. As South Korea progresses in adopting advanced formulations to support skin health, the aesthetic injectables market is projected to […]
Read more

Asia-Pacific outperforms other regions despite 1.4% drop in deal activity in 2024, reveals GlobalData

The Asia-Pacific (APAC) region saw a slight 1.4% decline in deal activity, with a total of 14,621 mergers & acquisitions (M&A), private equity, and venture financing deals in 2024 compared to the 14,829 deals announced during the previous year. Despite this dip, APAC outperformed other regions, reveals GlobalData, a leading data and analytics company. Aurojyoti […]
Read more

Goldman Sachs and Rothschild & Co top M&A financial advisers in Europe in 2024, reveals GlobalData

Goldman Sachs and Rothschild & Co were the top mergers and acquisitions (M&A) financial advisers in the European region in 2024 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database revealed that Goldman Sachs achieved its leading […]
Read more

Nvidia announcements at CES 2025 spark influencer discussions on AI future, reveals GlobalData

Nvidia made a strong impact at Consumer Electronics Show (CES) 2025, held from 7-10 January 2025, sparking positive discussions across social media. The key highlights driving excitement included the introduction of Agent AI, Project Digits—a $3,000 personal AI supercomputer—and the Cosmos world foundation models. These innovations fueled enthusiasm from industry leaders and influencers, positioning the […]
Read more

Global deal activity declines 6.7% in 2024 but resilience shines in some key markets, reveals GlobalData

A total of 50,523 deals across mergers & acquisitions (M&A), private equity, and venture financing were announced globally during 2024, reflecting a 6.7% year-on-year (YoY) decline from 54,141 deals announced in 2023. Despite the overall downturn, certain markets demonstrated resilience, highlighting the nuanced dynamics of the global deal-making landscape, according to GlobalData, a leading data […]
Read more

Financial accountability, Agentic AI, specialized and small language models are key trends shaping AI deployments in 2025, says GlobalData

The artificial intelligence (AI) landscape is evolving at a rapid pace. The key issues organizations face in 2025 include greater financial accountability, Agentic AI, domain-specific and small language models, and best practices to promote scalability, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “2025 Enterprise Predictions: Artificial Intelligence,” reveals that in […]
Read more

GLP-1R gold rush: Emerging biotechs set to challenge market leaders, says GlobalData

The glucagon-like peptide-1 receptor (GLP-1R) market experienced significant growth in 2023, generating $37.2 billion in sales, with Novo Nordisk and Eli Lilly dominating the sector. However, emerging biotech companies are poised to disrupt this landscape, with promising pipeline products expected to generate substantial revenue and challenge the market leaders by 2030, says GlobalData, a leading […]
Read more

AI is set to improve R&D productivity and lower the costs, says GlobalData

Artificial intelligence (AI) has the potential to significantly reduce pharmaceutical R&D costs by streamlining drug discovery, optimizing clinical trials, and minimizing costly failures through data-driven predictions and effectiveness assessments. This potential was acknowledged by the pharmaceutical industry professionals in a survey* conducted by GlobalData, a leading data and analytics company. GlobalData’s report, “The State of […]
Read more

APAC top 50 firms market cap reaches $8.1 trillion in 2024, led by tech giants amid economic uncertainty, says GlobalData

The combined market capitalization of the top 50 companies in the Asia-Pacific (APAC) region surged to $8.1 trillion in 2024, reflecting a 20.6% year-on-year increase. Technology firms led the charge, with Taiwan Semiconductor Manufacturing Company and Tencent Holdings dominating the rankings. However, economic uncertainty, trade risks, and weaker corporate earnings have tempered optimism across various […]
Read more

China at the forefront of global polypropylene capacity additions through 2028, says GlobalData

China is likely to register the highest polypropylene capacity additions globally by 2028, contributing about 45% of the total capacity additions from the upcoming planned and announced projects, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Polypropylene Industry Capacity and Capital Expenditure Forecasts with Details of Active and Planned Plants to […]
Read more

ProCook sees store expansion drive growth, says GlobalData

Following today’s release of ProCook’s figures for the 12 weeks ending 5 January 2025; Emily Scott, Retail Analyst at GlobalData, a leading data and analytics company, offers her view: “ProCook delivered a strong performance in its Q3 FY2024/25, with revenue increasing by an impressive 11.2%. This robust growth was largely driven by its focus on store […]
Read more

GlobalData 2025 cloud predictions: Data loss concerns will limit GenAI access for developers

Enterprises are expected to tighten restrictions on generative AI (GenAI) usage among developers, citing proprietary data concerns. Meanwhile, agentic AI is emerging as a critical upskilling opportunity for IT professionals, and open-source software (OSS) technologies are set to drive innovation in cloud-native development, according to the 2025 cloud predictions by GlobalData, a leading data and […]
Read more

Novartis gene therapy poised to expand SMA treatment landscape, says GlobalData

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) involving pediatric patients aged 2–17 years with type II spinal muscular atrophy (SMA). These positive results have the potential to broaden the eligible patient population for this gene transfer […]
Read more
1 … 42 43 44 45 46 … 209